Histological Improvements after a Three-Year Lamivudine Therapy in Patients with Chronic Hepatitis B in Whom YMDD Mutants Did Not or Did Develop

Publisher： Karger

E-ISSN： 1423-0100|46|3|164-170

ISSN： 0300-5526

Source： Intervirology, Vol.46, Iss.3, 2003-07, pp. : 164-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clearance of the original hepatitis B virus YMDD‐motif mutants with emergence of distinct lamivudine‐resistant mutants during prolonged lamivudine therapy

By  

HEPATOLOGY, Vol. 31, Iss. 6, 2000-06 ,pp. : 1318-1326

John Wiley & Sons Inc

Access to resources Recommend Favorite

Continued Lamivudine Therapy in Patients with Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 377-387

Karger

Access to resources Recommend Favorite

Characterization of Naturally Occurring and Lamivudine-Induced Surface Gene Mutants of Hepatitis B Virus in Patients with Chronic Hepatitis B in India

By  

Intervirology, Vol. 49, Iss. 3, 2006-01 ,pp. : 152-160

Karger

Access to resources Recommend Favorite

The Feasibility of Discontinuing Lamivudine in Lamivudine-Resistant Chronic Hepatitis B Patients on Lamivudine and Adefovir Combination Therapy

By  

Intervirology, Vol. 57, Iss. 6, 2014-09 ,pp. : 337-343

Karger

Access to resources Recommend Favorite

Short-Term Lamivudine Therapy in Patients with Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 362-366

Karger

Access to resources Recommend Favorite